ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 658371 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 658371; 2) Community: the network communities that were significantly associated with the response to NSC 658371; 3) Molecule: the relationships between components within communities and NSC 658371; 4) MDR: the compounds that were significantly associated with the NSC 658371.

NSC Compound Enrichment Correlation
NSC 683061 Null 0.0434721470609156 0.18339011
NSC 686551 Null 0.0434721470609156 0.15847529
NSC 6926 Null 0.0434721470609156 0.24928567
NSC 693248 Null 0.0434721470609156 0.21904365
NSC 717468 Null 0.0434721470609156 0.15820104
NSC 718564 Null 0.0434721470609156 0.20994915
NSC 718781 Erlotinib hydrochloride 0.0434721470609156 -0.08290255
NSC 720320 1,6-bis-(2,6-difluorobenzyl)-2-(2,6-difluorophenyl)-5-methoxy-benzimidazole 0.0434721470609156 -0.13068275
NSC 724783 [1,5-dimethyl-10-(trifluoromethyl)-11,14,15,16-tetraoxatetra cyclo[10.3.1.04,13.08,13]hexadec-9-en-9-yl]-N,N-bis{[1,5-dim ethyl-10-(trifluoromethyl)-11,14,15,16-tetraoxatetracyclo[10 .3.1.04,13.08,13 0.0434721470609156 0.22200608
NSC 726217 Combretastatin A4-analogue 0.0434721470609156 0.18453542
Total:166  Current:137    [First] [Prev] [Next] [Last]